Senior insider sale
Chief Business Development Off at NEUROCRINE BIOSCIENCES INC — senior position signals high conviction
$4.90M
36.70K shares
What this filing means
GANO KYLE plans to sell 36.70K shares of NEUROCRINE BIOSCIENCES INC valued at approximately $4.90M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2026ACC: 0001950047-26-000515
Officer· Chief Business Development Off
Since Aug 2018
36.70K
Shares to sell
$4.90M
Approx. market value
36.40K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
1/16/2026
36.40KTotal acquired36.40K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/16/2026 | Exercise of Stock Options Cash | 36.40K | — |
| Total | 36.40K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
300.00
Market value
$42.6K
11/4/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
36.40K
Market value
$4.85M
1/16/2026
Total
Units
36.70K
Value
$4.90M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
11/4/2025 | 300.00 | $42.6K | — | Completed |
| Planned — Approximate Date | ||||
1/16/2026 | 36.40K | $4.85M | NASDAQ | Planned |
| Total | 36.70K | $4.90M | ||